The epidemiology and risk factors for postnatal complications among postpartum women and newborns in southwestern Uganda: A prospective cohort study.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2024
Historique:
received: 08 08 2023
accepted: 13 06 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: epublish

Résumé

Sub-Saharan Africa accounts for two-thirds of the global burden of maternal and newborn deaths. Adverse outcomes among postpartum women and newborns occurring in the first six weeks of life are often related, though data co-examining patients are limited. This study is an exploratory analysis describing the epidemiology of postnatal complications among postpartum women and newborns following facility birth and discharge in Mbarara, Uganda. This single-site prospective cohort observational study enrolled postpartum women following facility-based delivery. To capture health information about both the postpartum women and newborns, data was collected and categorized according to domains within the continuum of care including (1) social and demographic, (2) pregnancy history and antenatal care, (3) delivery, (4) maternal discharge, and (5) newborn discharge. The primary outcomes were readmission and mortality within the six-week postnatal period as defined by the WHO. Multivariable logistic regression was used to identify risk factors. Among 2930 discharged dyads, 2.8% and 9.0% of women and newborns received three or more postnatal visits respectively. Readmission and deaths occurred among 108(3.6%) and 25(0.8%) newborns and in 80(2.7%) and 0(0%) women, respectively. Readmissions were related to sepsis/infection in 70(88%) women and 68(63%) newborns. Adjusted analysis found that caesarean delivery (OR:2.91; 95%CI:1.5-6.04), longer travel time to the facility (OR:1.54; 95%CI:1.24-1.91) and higher maternal heart rate at discharge (OR:1.02; 95%CI:1.00-1.01) were significantly associated with maternal readmission. Discharge taken on all patients including maternal haemoglobin (per g/dL) (OR:0.90; 95%CI:0.82-0.99), maternal symptoms (OR:1.76; 95%CI:1.02-2.91), newborn temperature (OR:1.66; 95%CI:1.28-2.13) and newborn heart rate at (OR:1.94; 95%CI:1.19-3.09) were risk factors among newborns. Readmission and death following delivery and discharge from healthcare facilities is still a problem in settings with low rates of postnatal care visits for both women and newborns. Strategies to identify vulnerable dyads and provide better access to follow-up care, are urgently required.

Identifiants

pubmed: 39110697
doi: 10.1371/journal.pgph.0003458
pii: PGPH-D-23-01338
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0003458

Informations de copyright

Copyright: © 2024 Pillay et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Yashodani Pillay (Y)

Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Institute for Global Health, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.

Joseph Ngonzi (J)

Department of Obstetrics and Gynaecology, Mbarara University of Science and Technology and Mbarara Regional Referral Hospital, Mbarara, Uganda.

Vuong Nguyen (V)

Institute for Global Health, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.

Beth A Payne (BA)

Digital Health, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.

Clare Komugisha (C)

WALIMU, Kololo, Kampala, Uganda.

Annet Happy Twinomujuni (AH)

WALIMU, Kololo, Kampala, Uganda.

Marianne Vidler (M)

Department of Obstetrics and Gynaecology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Pascal M Lavoie (PM)

Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Lisa M Bebell (LM)

Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Astrid Christoffersen-Deb (A)

Department of Obstetrics and Gynaecology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Nathan Kenya-Mugisha (N)

WALIMU, Kololo, Kampala, Uganda.

Niranjan Kissoon (N)

Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

J Mark Ansermino (JM)

Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Institute for Global Health, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.

Matthew O Wiens (MO)

Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Institute for Global Health, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
WALIMU, Kololo, Kampala, Uganda.

Classifications MeSH